Skip to main content

R3 Stem Cell in Top 10 Biotech Startups

R3 Stem Cell was recently named to Top 10 Biotech Startups 2021 by Life Sciences Review. This continues a plethora of Awards that R3 has been receiving over the past few years including best USA Regenerative Therapy Company, Most Innovative, Fastest Growing, and more.


”People ask us frequently how we can offer such high cell counts at pricing so low. We don’t sacrifice the quality of our biologics, we use our volume buying power to pass savings along to patients.” added Dr. David Greene Arizona.


Since its inception, R3 Stem Cell’s Centers of Excellence have performed 17,000 stem cell procedures globally. With an 85% year-over-year patient satisfaction, the company is truly at the forefront of the regenerative field. Why? According to Dr. David Greene R3 Stem Cell CEO, MD, Ph.D., MBA, “Patients at our Centers receive customized therapies based on their condition, severity, age, weight, and other factors. First, our providers figure out if a patient is a candidate, then tailor the regimen for the optimal outcome.”


With over 40 clinics worldwide, R3’s goal is to offer first-rate stem cell biologics to improve patients’ quality of life tremendously while at the same time remaining affordable. R3 offers stem cell therapy in Mexico, Pakistan, the Philippines, the USA, and others. Dr. Greene added, “People ask us frequently how we can offer such high cell counts at pricing so much lower than our competitors. We don’t sacrifice the quality of our biologics, but we use our volume buying power to pass savings along to patients.”


With over 50 different conditions being treated worldwide successfully, R3 is continuously looking at expansion into countries that may benefit from the treatments. The condition categories include cardiac, orthopedic, pulmonary, autoimmune, neurologic, urologic, endocrine, renal, autism, and more. The formula for success has been quality stem cell biologics, affordable treatments, compassionate and skilled providers along with a staff that treats patients like family.


R3 knows that advancements in the field of regenerative medicine only occur through research. According to CEO David Greene MD, Ph.D., MBA, “R3 not only provides first-rate regenerative therapies around the world, but we are also focusing on first-rate clinical research studies to move the field forward. These studies are being performed in countries where R3 has a presence, including the USA, Pakistan, Mexico, Philippines, and others.”


Current research studies focus on opiate addiction, erectile dysfunction, knee/shoulder arthritis, kidney failure, and Covid using stem cells and exosomes. R3 has a full research team focusing on Level 1 studies that are randomized, prospective, and double-blinded.


Labels:

Comments

Post a Comment

Popular posts from this blog

Reasons To Choose Stem Cell Therapy Over Surgery | Dr. David Greene Arizona

With aging, pain becomes the most exhausting experience. Consistently, many individuals look for treatment for shoulder, knee, back, or hip problems. Similarly, the amount of surgeries being performed has been on the rise, and entire knee and hip replacements rank among the most usually performed orthopedic treatment.  But is surgery the right option?  Before you take that jump, you need to think about the issues related to surgery and why stem cells may be a superior choice for you!  Stem Cell Treatment is cost-effective in the long run.  Both stem cell infusions and surgery are moderately costly techniques. You might like to settle on surgery since medical coverage might take care of the expenses. Your costs might be higher than you envision.  In addition, surgery requires sedation and pre-sedative examinations that can cost you time and cash. The long recuperation time after surgery may likewise bring about missed wages. Henceforth, over the long haul, you mi...
Post a Comment
Read more

Dr. David Greene: Arizona’s Pioneer of Regenerative Medicine and Founder of R3 Stem Cell

 In the ever-evolving world of modern healthcare, few names stand out quite like Dr. David Greene . Based in Arizona, Dr. Greene’s journey from practicing medicine as an orthopedic surgeon to becoming the founder and CEO of a global regenerative medicine company is nothing short of remarkable. After years of treating patients in the operating room, Dr. David Greene orthopedic surgeon began to notice a common thread—many patients were seeking alternatives to invasive procedures. That insight sparked a vision: to create a platform that provides cutting-edge, non-surgical treatment options using the body’s natural healing powers. That vision became reality with the founding of R3 Stem Cell in 2012. Under Dr. David Greene R3 Stem Cell has grown into a multi-national enterprise, offering regenerative therapies in over 45 centers across the U.S. and several countries, including Mexico, India, and the Philippines. These treatments are helping patients find relief from chronic pain...
Post a Comment
Read more

Dr. David Greene R3 Stem Cell: A Practical Path to Non Surgical Relief

If pain has been deciding what you can do how far you walk, how long you sit, or whether you play with the kids it may be time to explore Dr. David Greene R3 Stem Cell . Founded by physician and healthcare innovator Dr. David Greene , R3 focuses on regenerative therapies designed to support the body’s own repair processes so you can move with greater confidence and less downtime. A Patient First Model What sets Dr. David Greene R3 Stem Cell apart is a clear, step-by-step approach. Every visit begins with listening: your history, daily activities, and goals. Providers then complete a targeted exam and, when appropriate, review imaging. If you’re a candidate, a personalized plan is built around evidence-informed protocols rather than a one-size-fits-all procedure. What Treatments May Include R3 clinics offer a spectrum of regenerative options such as stem cell procedures, platelet-rich plasma (PRP), and exosome-based care performed in office with image guidance for precision. These ...
Post a Comment
Read more